Intellectual Property
AirZap Patents
AirZap is a single-pass HVAC UV-C (Ultraviolet-C) system. AirZap is designed to eradicate Pathogens, including COVID-19, SARS, Influenza, RSV, and other airborne pathogens, at a 99.997% rate.
Technology Innovation
Patented fin geometry and airflow optimization for single-pass treatment
LED Advancement
High-output UV-C LEDs with 10,000+ hour lifespan, zero ozone
99.997% Efficacy
Clinically validated pathogen elimination in one pass through HVAC system
Real-World Application
Seamless integration with existing HVAC systems, no infrastructure changes
Our Patents
Patent US10946321, PAT. D1120267 and other US and International patents pending. All rights reserved.
Single-Pass UV-C Sterilization System
A novel HVAC-integrated sterilization apparatus utilizing strategically positioned UV-C LEDs to achieve 99.997% pathogen elimination in a single air pass.
AirZap Design Patent
Design patent for the AirZap UV-C air purification system.
Patent Notice: The information provided here is for informational purposes only and should not be considered legal advice. For complete patent details, claims, and drawings, please visit the USPTO website. AirZap reserves all intellectual property rights.
Backed by Innovation
AirZap's patented technologies represent a breakthrough in HVAC-integrated air sterilization. Our commitment to innovation ensures contractors and homeowners have access to the most advanced indoor air quality solution available.